References
- Vaamonde CA. Risk factors in nephrotoxicity. In: Strauss J, ed. Pediatric nephrology seminars. Amsterdam: Martinus Nijhoff/W Funk Publishers, Amsterdam 1986: 49–85
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1): 31–41
- Hadj-Aissa A, Dumarest C, Maire P, et al. Renal function in the elderly. Nephron 1990; 54(4): 364–5
- Vaamonde CA. Selected renal and electrolyte abnormalities in renal disease. AKF Nephrology Letter 1992; 9: 13–28
- Garella S. Drug-induced renal disease. Hosp Pract (Off Ed) 1993; 28(4): 129–40
- Barrett BJ. Contrast nephrotoxicity. (Editorial) J Am Soc Nephrol 1994; 5(2): 125–37
- Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6(5): 1451–8
- Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89(5): 615–20
- Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45(1): 259–65
- Rudnick MR, Goldiarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47(1): 254–61
- Cantley LG, Spokes K, Clark B, et al. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993; 44(6): 1217–23
- Agmon Y, Peleg H, Greenfeld Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94(3): 1069–75
- Powe NR. Low-versus high-osmolality contrast media for intravenous use: a health care luxury or necessity? Radiology 1992; 183(1): 21–2
- Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331(21): 1416–20
- Leehey DJ, Braun BI, ThoU DA, et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J Am Soc Nephrol 1993; 4(1): 81–90
- Vaamonde CA. Antibiotic-induced nephrotoxicity. In: Robinson RR, ed. Nephrology. New York: Karger 1984: 844–68
- Kaloyanides GJ. Aminoglycoside nephrotoxicity. In: Schrier CW, Gottschalk CW, eds. Diseases of the kidney. 5 th ed. Boston: Little, Brown 1993: 1131–64
- Weinberg JM. The cellular basis of nephrotoxicity. In: Schrier, Gottschalk, eds, 17 pp 1031–97
- Farquhar MG. The unfolding story of megalin (gp330): now recognized as a drug receptor. (Editorial) J Clin Invest 1995: 96(3): 1184
- Barza M, Ioannidis JP, Cappelleri JC, et al. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312(7027): 338–45
- Palmer BF, Henrich WL. Clinical acute renal failure with nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995; 15(3): 214–27
- Haragsim L, Dalai R, Bagga H, et al. Ketorolac-induced acute renal failure and hyperkalemia: report of three cases. Am J Kidney Dis 1994; 24(4): 578–80
- Kirschenbaum M, Shah G. Nephropathy of nonsteroidal antiinflammatory agents. In: Massry SG, Glassock RJ, eds. Textbook of nephrology. 3d ed. Baltimore: Williams & Wilkins, 1995: 940–7
- Kleinknecht D. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995; 15(3): 228–35
- Hricik DE, Dunn MJ. Angiotensin-Converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990; 1(6): 845–58
- Textor SC, Novick AC, Tarazi RC, et al. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 1985; 102(3): 308–14